No information is present at this moment.
On-label
Licensed use Licensed usePer ml oordr.: Polymyxine-B-sulfaat 10000 IE Neomycinesulfaat 10 mg Fludrocortisonacetaat 1 mg Lidocaïnehydrochloride (als 1-water) 40 mg
| External ear inflammation, secondary infection with microorganisms that are susceptible to neomycin and/or polymyxin B-sulphate |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Irritatie en branderig gevoel. Algemene bijwerkingen kunnen na langdurig gebruik van corticosteroïden optreden. Overgevoeligheidsverschijnselen. Sensibilisatie door neomycine treedt frequent. Langdurig gebruik van corticosteroïden in het oor kan leiden tot atrofie en perforatie van het trommelvlies.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Aandoeningen, primair veroorzaakt door een bacterie, virus, schimmel, gist of parasiet. Ulcereuze aandoeningen, wonden. Geperforeerd trommelvlies. Overgevoeligheid voor corticosteroïden of aminoglycosiden.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific warnings and precautions in children.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Corticosteroids and antiinfectives in combination | ||
|---|---|---|
| S02CA03 | ||
| S02CA03 | ||
| S02CA06 | ||
| S02CA07 | ||
| S02CA03 | ||
| S02CA03 | ||
| S02CA04 | ||